Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression
Authors
Keywords
-
Journal
Molecular Genetics & Genomic Medicine
Volume -, Issue -, Pages e554
Publisher
Wiley
Online
2019-01-09
DOI
10.1002/mgg3.554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1)
- (2018) Jing Du et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression
- (2018) Jia Pan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
- (2017) A Besse et al. LEUKEMIA
- Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer
- (2016) Zhentong Wei et al. MEDICAL ONCOLOGY
- Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo
- (2016) See-Hyoung Park et al. Oncotarget
- Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin
- (2015) Ying-Min Wu et al. Oncotarget
- Transcriptional factor FOXO3 negatively regulates the expression of nm23-H1 in non-small cell lung cancer
- (2015) Linlin Zhang et al. Thoracic Cancer
- FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis
- (2014) Jiao Wang et al. APOPTOSIS
- Knockdown of MDR1 Increases the Sensitivity to Adriamycin in Drug Resistant Gastric Cancer Cells
- (2014) Chun-Yu Zhu et al. Asian Pacific Journal of Cancer Prevention
- FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role
- (2013) M D Bullock et al. BRITISH JOURNAL OF CANCER
- MicroRNA-195 Chemosensitizes Colon Cancer Cells to the Chemotherapeutic Drug Doxorubicin by Targeting the First Binding Site of BCL2L2 mRNA
- (2013) Juan Qu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
- (2013) Ana R. Gomes et al. Chinese Journal of Cancer
- β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
- (2012) Stephan P Tenbaum et al. NATURE MEDICINE
- Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells
- (2012) X. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer
- (2010) Jer-Yen Yang et al. CANCER RESEARCH
- MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer
- (2009) Bernard Paule et al. MEDICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started